insights_auto
Why is PGEN down 2.35%?
Dive Deeperchevron_right
PGEN:NASDAQ
Precigen Inc
$7.48
arrow_downward
-2.35%(-0.18) 1D
$7.48
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 13, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PGEN...
Open
$7.60
High
$7.71
Low
$7.48
Mkt. cap
2.68B
Avg. vol.
4.74M
Volume
2.40M
52-wk high
$8.98
52-wk low
$3.04
EPS
-$1.10
Beta
0.92
Shares outstanding
358.04M
No. of employees
160
Open
$7.60
High
$7.71
Low
$7.48
Mkt. cap
2.68B
Avg. vol.
4.74M
Volume
2.40M
52-wk high
$8.98
52-wk low
$3.04
EPS
-$1.10
Beta
0.92
Shares outstanding
358.04M
No. of employees
160
News stories
From web sources and news partners
Yahoo Finance
·
1 day ago
Precigen (PGEN): Commercial Launch Success Validates Early Capital Raise Thesis
Profile
Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari.
Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Wikipedia
About Precigen Inc
CEOHelen Sabzevari
Employees160
FoundedMay 21, 1998
Headquarters-
SectorBiotechnology
Websiteprecigen.com